• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗安全性评估的流行病学设计:方法与陷阱

Epidemiological designs for vaccine safety assessment: methods and pitfalls.

作者信息

Andrews Nick

机构信息

Statistics Modelling and Economics Department, Health Protection Services, Health Protection Agency, 61 Colindale Avenue, London, NW9 5EQ, UK.

出版信息

Biologicals. 2012 Sep;40(5):389-92. doi: 10.1016/j.biologicals.2011.08.010. Epub 2011 Oct 8.

DOI:10.1016/j.biologicals.2011.08.010
PMID:21985898
Abstract

Three commonly used designs for vaccine safety assessment post licensure are cohort, case-control and self-controlled case series. These methods are often used with routine health databases and immunisation registries. This paper considers the issues that may arise when designing an epidemiological study, such as understanding the vaccine safety question, case definition and finding, limitations of data sources, uncontrolled confounding, and pitfalls that apply to the individual designs. The example of MMR and autism, where all three designs have been used, is presented to help consider these issues.

摘要

三种常用于疫苗上市后安全性评估的设计是队列研究、病例对照研究和自我对照病例系列研究。这些方法经常与常规健康数据库和免疫登记系统一起使用。本文探讨了在设计流行病学研究时可能出现的问题,例如理解疫苗安全性问题、病例定义与发现、数据来源的局限性、未控制的混杂因素以及适用于个别设计的陷阱。文中给出了麻疹、腮腺炎和风疹联合疫苗(MMR)与自闭症关系的例子,在该例子中这三种设计都曾被使用,以此来帮助思考这些问题。

相似文献

1
Epidemiological designs for vaccine safety assessment: methods and pitfalls.疫苗安全性评估的流行病学设计:方法与陷阱
Biologicals. 2012 Sep;40(5):389-92. doi: 10.1016/j.biologicals.2011.08.010. Epub 2011 Oct 8.
2
Postlicensure epidemiology of childhood vaccination: the Danish experience.儿童疫苗接种后许可流行病学:丹麦的经验。
Expert Rev Vaccines. 2006 Oct;5(5):641-9. doi: 10.1586/14760584.5.5.641.
3
MMR and autism: the debate continues.麻疹、腮腺炎、风疹疫苗与自闭症:争论仍在继续。
Lancet. 2004 Feb 14;363(9408):567-8; author reply 568-9. doi: 10.1016/S0140-6736(04)15549-9.
4
Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations.四种评估疫苗安全性的不同研究设计都得到了同样的验证,但各有不同的局限性。
J Clin Epidemiol. 2006 Aug;59(8):808-18. doi: 10.1016/j.jclinepi.2005.11.012. Epub 2006 Mar 15.
5
Autism and MMR vaccination in North London; no causal relationship.北伦敦地区的自闭症与麻疹、腮腺炎和风疹疫苗接种;无因果关系。
Mol Psychiatry. 2002;7 Suppl 2:S7-8. doi: 10.1038/sj.mp.4001163.
6
[Lack of association between MMR vaccination and the incidence of autism in children: a case-control study].[麻疹、腮腺炎和风疹联合疫苗接种与儿童自闭症发病率之间缺乏关联:一项病例对照研究]
Przegl Epidemiol. 2009;63(1):107-12.
7
Measles, mumps, and rubella (MMR) vaccine and autism. Ecological studies cannot answer main question.麻疹、腮腺炎和风疹(MMR)疫苗与自闭症。生态学研究无法回答主要问题。
BMJ. 2001 Jul 21;323(7305):163; author reply 164.
8
An epidemiological study on Japanese autism concerning routine childhood immunization history.一项关于日本自闭症与儿童常规免疫接种史的流行病学研究。
Jpn J Infect Dis. 2003 Jun;56(3):114-7.
9
A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism.含硫柳汞的儿童疫苗中MMR免疫接种和汞剂量对自闭症人群患病率影响的比较评估。
Med Sci Monit. 2004 Mar;10(3):PI33-9. Epub 2004 Mar 1.
10
Lack of association between measles-mumps-rubella vaccination and autism in children: a case-control study.麻疹-腮腺炎-风疹疫苗接种与儿童自闭症之间缺乏关联:病例对照研究。
Pediatr Infect Dis J. 2010 May;29(5):397-400. doi: 10.1097/INF.0b013e3181c40a8a.

引用本文的文献

1
The WHO Algorithm for Causality Assessment of Adverse Effects Following Immunization with Genetic-Based Anti-COVID-19 Vaccines: Pitfalls and Suggestions for Improvement.世界卫生组织基于基因的抗COVID-19疫苗接种后不良反应因果关系评估算法:陷阱与改进建议
J Clin Med. 2024 Nov 30;13(23):7291. doi: 10.3390/jcm13237291.
2
Selecting the most informative positive and negative controls for self-controlled case series (SCCS): Rationale, approach, and lessons from studies investigating the safety of COVID-19 vaccines.为自我对照病例系列(SCCS)选择最具信息性的阳性和阴性对照:原理、方法以及来自调查新冠病毒疫苗安全性研究的经验教训。
J Glob Health. 2024 Aug 6;14:03037. doi: 10.7189/jogh.14.03037.
3
COVID-19 Vaccine Safety Monitoring Studies in Low- and Middle-Income Countries (LMICs)-A Systematic Review of Study Designs and Methods.
低收入和中等收入国家(LMICs)的COVID-19疫苗安全性监测研究——研究设计与方法的系统评价
Vaccines (Basel). 2023 May 29;11(6):1035. doi: 10.3390/vaccines11061035.
4
Safety of COVID-19 booster dose: is the juice worth the squeeze?新冠病毒加强针的安全性:费力是否值得?
Lancet Infect Dis. 2023 Oct;23(10):1097-1099. doi: 10.1016/S1473-3099(23)00296-7. Epub 2023 Jun 20.
5
The public health value of vaccines beyond efficacy: methods, measures and outcomes.疫苗超出效力之外的公共卫生价值:方法、措施与结果
BMC Med. 2017 Jul 26;15(1):138. doi: 10.1186/s12916-017-0911-8.